More must be done to reduce cardiovascular risk for patients on antipsychotic medications

Emanuele F. Osimo^*, Benjamin I. Perry, Graham K. Murray

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	179-181
Number of pages	3
Journal	International Clinical Psychopharmacology
Volume	38
Issue number	3
DOIs	https://doi.org/10.1097/YIC.0000000000000464
Publication status	Published - May 2023

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{b1f7cd1b74c549b591da5fb016b980d4,

title = "More must be done to reduce cardiovascular risk for patients on antipsychotic medications",

author = "Osimo, {Emanuele F.} and Perry, {Benjamin I.} and Murray, {Graham K.}",

year = "2023",

month = may,

doi = "10.1097/YIC.0000000000000464",

language = "English",

volume = "38",

pages = "179--181",

journal = "International Clinical Psychopharmacology",

issn = "0268-1315",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - More must be done to reduce cardiovascular risk for patients on antipsychotic medications

AU - Osimo, Emanuele F.

AU - Perry, Benjamin I.

AU - Murray, Graham K.

PY - 2023/5

Y1 - 2023/5

UR - http://www.scopus.com/inward/record.url?scp=85151388673&partnerID=8YFLogxK

U2 - 10.1097/YIC.0000000000000464

DO - 10.1097/YIC.0000000000000464

M3 - Comment/debate

C2 - 36947405

AN - SCOPUS:85151388673

SN - 0268-1315

VL - 38

SP - 179

EP - 181

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

IS - 3

ER -